Raydiant Oximetry

San Ramon, United States Founded: 2015 • Age: 11 yrs
Wearable device for non-invasive fetal blood oxygen monitoring is offered.

About Raydiant Oximetry

Raydiant Oximetry is a Consumer company based in San Ramon (United States) founded in 2015 by Neil Ray. Wearable device for non-invasive fetal blood oxygen monitoring is offered. It operates on a HealthTech model in Consumer, Healthcare, and Technology sectors. Raydiant Oximetry has raised $25.7 million across 14 funding rounds from investors including March of Dimes, HHS and VCI Global. Its chief executive, as recorded, is Neil Ray. Raydiant Oximetry offers products and services including Lumerahâ„¢. Its focus areas include Medical Devices and Fetal Monitoring. Its legal entity is Raydiant Oximetry, Inc. Its competitors include kegg, Femometer and Noninvasix; 2 of its 3 listed competitors have raised funding.

Company details

Raydiant Oximetry, Inc. is focused on advancing fetal health monitoring during childbirth. The company is developing Lumerah, a noninvasive fetal pulse oximeter designed to measure fetal oxygen levels accurately. This technology aims to reduce maternal and neonatal mortality and morbidity by providing healthcare professionals with reliable data for decision-making during labor and delivery. Operating in the healthcare sector, specifically in medical devices, solutions are targeted at improving outcomes in obstetrics. Partnerships with organizations like GE HealthCare further support the enhancement of fetal monitoring capabilities.

  • Headquarters San Ramon, United States
  • Founders Neil Ray
  • Sectors
    Consumer
    Healthcare Technology
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website raydiantoximetry.com
  • Social LinkedIn X
  • Legal Name Raydiant Oximetry, Inc.
Key Metrics
  • Total Equity Funding
    $25.7M (USD)

    in 14 rounds

  • Latest Funding Round
    $7.5M (USD), Series A

    May 2024

  • Investors

Products & Services of Raydiant Oximetry

Raydiant Oximetry offers a comprehensive portfolio of products and services, including Lumerah™.

Lumerah™
Medical Device

Noninvasive fetal pulse oximeter for oxygenation monitoring.

Funding Insights of Raydiant Oximetry

Raydiant Oximetry has successfully raised a total of $25.7M across 14 strategic funding rounds. The most recent funding activity was a Series A round of $7.5 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $25.7M
  • Total Rounds 14
  • Last Round Series A — $7.5M
  • First Round $1.94M

    (Jul 2018)

  • Investors Count 18

Latest 10 of 14 funding rounds of Raydiant Oximetry with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
May 2024$7.5MSeries A–Cross Border Impact Ventures
Feb 2023Series A–March of Dimes
–
Jul 2021$5MSeries A–Avestria Ventures
Aug 2020$999,392Grant––
Jul 2020$203,353Grant––
Feb 2020$50,000Series A––
–
Dec 2019$900,000Series A––
–
Oct 2019$5.6MSeries A–VCapital
Sep 2019$3.17MSeries A––
–
May 2019$2.48MSeed––
–
Valuation history

18 investors in total: 18 institutional.

Investors in Raydiant Oximetry

Raydiant Oximetry has secured backing from 18 investors, including venture fund and institutional investors. Prominent investors backing the company include March of Dimes, HHS and VCI Global.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Investments are focused on health technology for global impact.
crossborder.venturesToronto, Canada
Venture capital investment opportunities are provided for accredited investors.
vcapital.com
Avestria Ventures is focused on funding women's health and life science ventures.
avestria.vcSan Francisco, United States
Angel investing in high-tech and life science startups since 1994.
bandangels.com
Investments are focused on reproductive healthcare startups by Rhia Ventures.
rhiaventures.orgSan Francisco, United States
Investments are focused on innovations in women's health.
2019femhealthventures.com
Investments in healthcare startups are managed by SteelSky Ventures.
steelskyventures.comAtlanta, United States
VC funds investing in technology startups
trivalleyventures.comPleasanton, United States
Kofa Healthcare is engaged in funding healthcare and biotech innovations.
kofahealthcare.com
Venture capital fund backed by the US Government
seedfund.nsf.govAlexandria, United States
Premium access

Investor details for Raydiant Oximetry

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Raydiant Oximetry

26 people are tracked at Raydiant Oximetry (12 in leadership, 10 in board & advisors, 4 in team).

NameRoleGroup
Neil Ray
Founder & CEOLeadership
Annie Theriault
DirectorLeadership
Debra Snowdale
CFOLeadership
Eric Johansson
VP Of R&dLeadership
Laura Kemp
Vice President Clinical AffairsLeadership
Russ DeLonzor
President And Chief Operating OfficerLeadership
Robert Skidmore
Vice President Of ManufacturingLeadership
Paul Stetson
Chief Scientific OfficerLeadership
Mark Rosen
Chief Medical OfficerLeadership
Elizabeth Bailey
DirectorLeadership
Denise Malvehy
Vp, Global MarketingLeadership
Maureen A. Brennan
Director Of Clinical Research And Professional Education For Radiant OximetryLeadership
Charles McDonald
DirectorBoard & advisors
Jana Kainerstorfer
AdvisorBoard & advisors
Tom Garite
AdvisorBoard & advisors
Nate DeNicola
AdvisorBoard & advisors
Denise Zarins
AdvisorBoard & advisors
Declan O'Mahoney
AdvisorBoard & advisors
David Boas
AdvisorBoard & advisors
Edward Evantash
AdvisorBoard & advisors

6 more people are available in the full profile.

Premium access

Complete people profiles for Raydiant Oximetry

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Raydiant Oximetry

3 dated milestones of Raydiant Oximetry across 9 years, from founding to its latest funding, stage changes and deals.

  1. Founded Raydiant Oximetry is founded.
  2. Funding First funding round of $1.9M.
  3. Funding Latest funding round, Series A, of $7.5M.

Competitors of Raydiant Oximetry

Raydiant Oximetry has 3 listed competitors in our database, 2 of them funded. They include kegg, Femometer and Noninvasix.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
kegg.tech2017San Francisco, United States$9.5M3
Fertility tracking and pelvic health solutions are provided by kegg.
femometer.com2015San Francisco, United States
Basal body temperature is tracked by Femometer for cycle monitoring.
noninvasix.com2007Galveston, United States$5.95M
Developer of a fetal blood oxygenation monitoring device
Premium access

Detailed competitors of Raydiant Oximetry

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Raydiant Oximetry

The website of Raydiant Oximetry (raydiantoximetry.com) receives about 1.4K visits a month.

  • Monthly visits
    1.4K

    ▼ 30.1% vs previous month

Similar websites

Websites whose visitors overlap most with Raydiant Oximetry. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
startuptrivalley.org
startuptrivalley.org
100%
#8,625,407–
vcapital.com
93%
#6,797,256View details

Top companies in Beauty & Personal Care Products

3 companies that operate in the same segment as Raydiant Oximetry (Beauty & Personal Care Products) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
3M is recognized as a global leader in industrial innovation.
1902United StatesUSD 24.95 B74
Provider of FMCG conglomerate products
1837United StatesUSD 457.23 M923
Subscription-based men's grooming products are provided by Harry's.
2012New York, New York, United StatesUSD 755.88 M431
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Raydiant Oximetry

Premium access

Complete news archive for Raydiant Oximetry

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Raydiant Oximetry

Raydiant Oximetry was founded in 2015 and raised its 1st funding round 3 years after it was founded.

Raydiant Oximetry is headquartered in San Ramon, United States. It is registered at San Ramon, California, United States.

Neil Ray is the CEO of Raydiant Oximetry, as recorded in our data. They have also founded this company.

Raydiant Oximetry is a funded company, having raised a total of $25.7M across 14 funding rounds to date. The company's 1st funding round was a Seed of $2.48M, raised on Jul 2018.

Raydiant Oximetry, Inc. is focused on advancing fetal health monitoring during childbirth. The company is developing Lumerah, a noninvasive fetal pulse oximeter designed to measure fetal oxygen levels accurately. This technology aims to reduce maternal and neonatal mortality and morbidity by providing healthcare professionals with reliable data for decision-making during labor and delivery. Operating in the healthcare sector, specifically in medical devices, solutions are targeted at improving outcomes in obstetrics. Partnerships with organizations like GE HealthCare further support the enhancement of fetal monitoring capabilities.

Raydiant Oximetry's top competitors include kegg, Femometer and Noninvasix.

Raydiant Oximetry offers Lumerahâ„¢.

Raydiant Oximetry has 18 investors. Key investors include March of Dimes, HHS, VCI Global, AngelMD, and Global Health Impact Network.

Raydiant Oximetry operates through Raydiant Oximetry, Inc..

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available